SCHEMBL3933846

SCHEMBL3933846

[c]1nc2ccccc2cc1-c1nccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
MAPT P10636 5/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
GLA P06280 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PLAU P00749 2/20 0.40
CYP2A6 P11509 1/20 0.40
F12 P00748 1/20 0.40
NCF1 P14598 1/20 0.40
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
BACE1 P56817 1/20 0.40
MAPK1 P28482 2/20 0.39
GPR55 Q9Y2T6 1/20 0.38
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9032374 0.78 CYP1A2 (0.49) KDM4EMAPTNPC1RAB9ANCF1
SCHEMBL10640426 0.77 KDM4E (0.38) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL938744 0.77 ALDH1A1 (0.40) KDM4EMAPTNPC1RAB9ACYP2A6
SCHEMBL1557837 0.76 MAPT (0.42) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL2187375 0.76 KMT2A (0.42) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL1385432 0.75 ALDH1A1 (0.42) KDM4EMAPTNPC1RAB9AGLA
SCHEMBL4875674 0.74 MAPT (0.39) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL29923403 0.73 PLAU (0.60) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL199273 0.73 PLAU (0.60) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL5516956 0.73 ESR1 (0.44) KDM4EMAPTGLAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572913-B2 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine BIOAXONE THERAPEUTIQUE INC. (CA) 2009-08-11 US claimed
US-6613776-B2 Protein serine/threonine kinase inhibitors used for treating diseases such as cancer, diabetes and Alzheimer's disease VERTEX PHARMACEUTICALS INCORPORATED 2003-09-02 US claimed
EP-0302389-A2 Alpha-unsaturated amines, their production and use Takeda Chemical Industries, Ltd. (JP) 1989-02-08 EP claimed
CN-115504896-B Acrylic formate compound for LED photopolymerization, preparation method and application thereof 湖北固润科技股份有限公司 2024-05-07 CN disclosed
EP-2845854-B1 DEUTERATED BENZOPYRAN COMPOUND AND APPLICATION THEREOF GUANGZHOU INST BIOMED & HEALTH (CN) 2016-09-21 EP disclosed
EP-2845854-A1 DEUTERATED BENZOPYRAN COMPOUND AND APPLICATION THEREOF Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences (CN) 2015-03-11 EP disclosed
CN-102741258-A Compositions and methods of cyclofructans as separating agents UNIV TEXAS 2012-10-17 CN disclosed
US-7105682-B2 Substituted amine derivatives and methods of use AMGEN INC. (US) 2006-09-12 US disclosed
EP-1053241-A1 NOVEL DIMERIZING AGENTS, THEIR PRODUCTION AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2000-11-22 EP disclosed
WO-1999041258-A1 NOVEL DIMERIZING AGENTS, THEIR PRODUCTION AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1999-08-19 WO disclosed
US-5491149-A VIRICIDES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-02-13 US disclosed
US-5003097-A Method for the sulfurization of phosphorous groups in compounds THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1991-03-26 US disclosed
EP-0081094-A1 Substituted omega-amino-carboxymethyldipeptide antihypertensive agents MERCK & CO. INC. (US) 1983-06-15 EP disclosed